Dear Allstat Permanent: Essential: Educated to Msc level in statistic or related subject, Minimum of 3-5 years of experience as a biostatistician within the pharmaceutical or CRO industry. Experience in working on phases I - IV, ideally phase II and III. Excellent SAS programming knowledge, ideally 2-3 years of experience in SAS programming. Working for this major client, you will be working on their Oncology and Cardiovascular studies. SAS base, SAS macro, SAS stat, study design and study analysis are part of your day to day routine. Salary: £32000 - £50 000- My client will also provide you with £1000 for relocation, will help you with finding accommodation. Bonus Scheme is included. Tina Fakharan Recruitment consultant Pharmaceutical, Healthcare & CRO division. 1st IT People Tel: +44 (0) 207 940 3900 Fax: +44 (0) 207 886 8161 mailto:[log in to unmask] www.1st-itpeople.com Offices in UK, Switzerland, The Netherlands & Hong Kong This email is confidential and intended solely for the use of the individual to whom it is addressed. Any views or opinions presented are solely those of the author and do not represent those of the company from which the email was sent. If you are not the intended recipient, be advised that you have received this e-mail in error and that any use, dissemination forwarding, printing or copying of this e-mail is strictly prohibited. While every effort has been made to scan this e-mail, we can not accept any responsibility for loss of business or damage caused arising from this e-mail. This email is confidential and intended solely for the use of the individual to whom it is addressed. Any views or opinions presented are solely those of the author and do not represent those of the company from which the email was sent. If you are not the intended recipient, be advised that you have received this e-mail in error and that any use, dissemination forwarding, printing or copying of this e-mail is strictly prohibited. While every effort has been made to scan this e-mail, we can not accept any responsibility for loss of business or damage caused arising from this e-mail.